Stereoselective urinary excretion of bupivacaine and its metabolites during epidural infusion

Chirality

Volumn 11, Issue 1, 1999, Pages 50-55

  Fawcett, J Paul ^a   Kennedy, Julia ^a   Kumar, Ashok ^a   Ledger, Robin ^a   Zacharias, Mathew ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bupivacaine enantiomers; Bupivacaine metabolites; Chiral chromatography; Human; Urine

Indexed keywords

3' HYDROXYBUPIVACAINE; 4' HYDROXYBUPIVACAINE; BUPIVACAINE; DESBUTYLBUPIVACAINE; DRUG METABOLITE; ROPIVACAINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHIRAL CHROMATOGRAPHY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG EXCRETION; ENANTIOMER; EPIDURAL DRUG ADMINISTRATION; HUMAN; MALE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; STEREOCHEMISTRY; URINARY EXCRETION;

AGED; ANALGESIA, EPIDURAL; ANESTHETICS, LOCAL; BIOTRANSFORMATION; BUPIVACAINE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 0032958061     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1999)11:1<50::AID-CHIR9>3.0.CO;2-I     Document Type: Article

References (27)

1. Tucker GT, Mather LE. Properties, absorption, disposition of local anaesthetic agents. In: Cousins MJ, Bridenbaugh PO, editors. Neural blockade in clinical anesthesia and management of pain. Philadelphia: J.B. Lippincott; 1988. p 89.
2. Reynolds F. Metabolism and excretion of bupivacaine in man: a comparison with mepivacaine. Br J Anaesth 1971;43:33-36.
3. Caldwell J, Notorianni LJ, Smith RL, Snedden W. The metabolism of bupivacaine in the rat. Proceedings of the British Pharmacological Society. Br J Pharmacol 1977;61:135P.
4. Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in sheep. Br J Anaesth 1991;67:239-246.
5. Rutten AJ, Mather LE, McLean CF. Cardiovascular effects and regional clearances of i.v. bupivacaine in sheep: enantiomeric analysis. Br J Anaesth 1991;67:247-256.
6. Burm AGL, van der Meer AD, van Kleef JW, Zeijlmans PWM, Groen K. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994;38: 125-129.
7. Mather LE, McCall P, McNicol PL. Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplantation patients. Anesth Analg 1995;80:328-335.
8. Lee JDL, Ang SB, Lee TL. Stereoselective high-performance liquid chromatographic assay for bupivacaine enantiomers. J Chromatogr 1987;420:203-206.
9. Abraham I, Fawcett JP, Kennedy J, Kumar A, Ledger R. Simultaneous analysis of lignocaine and bupivacaine enantiomers in plasma by high-performance liquid chromatography. J Chromatogr B 1997;703:203-208.
10. Berrisford G, Sabanathan S, Mearns AJ, Clarke BJ. Plasma concentrations of bupivacaine and its enantiomers during continuous extrapleural intercostal nerve block. Br J Anaesth 1993;70:201-204.
11. Clark BJ, Hamdi A, Berrisford RG, Sabanatham S, Mearns AJ. Reversed-phase and chiral high-performance liquid chromatographic assay of bupivacaine and its enantiomers in clinical samples after continuous extrapleural infusion. J Chromatogr 1991;553:383-390.
12. Bacsik CJ, Swift JQ, Hargereaves KM. Toxic systemic reactions of bupivacaine and etidocaine. Oral Surg Oral Med Oral Pathol 1995;79: 18-23.
13. Vanhoutte F, Vereecke J, Verbeke N, Carmeliet E. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol 1991;103: 1275-1281.
14. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anaesthetized rat. Reg Anesth 1992;17:477-482.
15. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993;77:477-482.
16. McClure JH. Ropivacaine. Br J Anaesth 1996;76:300-307.
17. Scott B, Lee A Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989;69:563-569.
18. Aberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol 1972;31:273-286.
19. Rosenberg PH, Heavner JE. Acute cardiovascular and central system toxicity of bupivacaine and desbutylbupivacaine in the rat. Acta Anaesthesiol Scand 1992;36:138-141.
20. Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M. Metabolism and excretion of ropivacaine in humans. Drug Metab Dispos 1996;24:962-968.
21. 1-acid glycoprotein column. J Chromatogr 1984;298:67-68.
22. Levy RH, Boddy AV. Stereoselectivity in pharmacokinetics: a general theory. Pharm Res 1991;8:551-556.
23. Rosenberg PH, Pere P, Hekali R, Tuominen M. Plasma concentrations of bupivacaine and two of its metabolites during continuous interscalene brachial plexus block. Br J Anaesth 1991;66:25-30.
24. Tuominen M, Rosenberg PH. Cumulation of bupivacaine, desbutyl-bupivacaine and 4′-hydroxybupivacaine during and after continuous interscalene brachial plexus block. Acta Anaesth Scand 1991;35:647-650.
25. Lindberg RLP. Simultaneous determination of bupivacaine and its two metabolites, desbutyl- and 4′-hydroxybupivacaine in human serum and urine. J Chromatogr B 1986;383:357-364.
26. Kastrissios H, Hung M-F, Triggs EJ. High-performance liquid chromatographic method for the quantitation of bupivacaine. 2,6-pipecoloxylidide and 4′-hydroxybupivacaine in plasma and urine. J Chromatogr B 1992;577:103-107.
27. Burm AGL, Vermeulen NPE, van Kleef JW, de Boer AG, Spierdijk J, Breimer DD. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Clin Pharmacokinet 1987;13:191-203.